Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs2853669

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr5:1295234 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
A>C / A>G / A>T
Variation Type
SNV Single Nucleotide Variation
Frequency
G=0.246095 (65139/264690, TOPMED)
G=0.241738 (33822/139912, GnomAD)
G=0.26641 (7623/28614, ALFA) (+ 15 more)
G=0.25480 (7196/28242, 14KJPN)
G=0.25322 (4243/16756, 8.3KJPN)
G=0.2918 (1869/6404, 1000G_30x)
G=0.2979 (1492/5008, 1000G)
G=0.2397 (1074/4480, Estonian)
G=0.3249 (1252/3854, ALSPAC)
G=0.3223 (1195/3708, TWINSUK)
G=0.3257 (936/2874, KOREAN)
G=0.3205 (568/1772, Korea1K)
G=0.267 (160/600, NorthernSweden)
A=0.310 (88/284, SGDP_PRJ)
G=0.398 (86/216, Qatari)
G=0.472 (100/212, Vietnamese)
G=0.35 (14/40, GENOME_DK)
A=0.39 (15/38, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
TERT : 2KB Upstream Variant
Publications
73 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20230706150541
Population Group Sample Size Ref Allele Alt Allele
Total Global 28614 A=0.73359 G=0.26641
European Sub 21250 A=0.69506 G=0.30494
African Sub 5558 A=0.8820 G=0.1180
African Others Sub 198 A=0.955 G=0.045
African American Sub 5360 A=0.8793 G=0.1207
Asian Sub 146 A=0.596 G=0.404
East Asian Sub 120 A=0.608 G=0.392
Other Asian Sub 26 A=0.54 G=0.46
Latin American 1 Sub 146 A=0.788 G=0.212
Latin American 2 Sub 610 A=0.766 G=0.234
South Asian Sub 98 A=0.51 G=0.49
Other Sub 806 A=0.744 G=0.256


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 A=0.753905 G=0.246095
gnomAD - Genomes Global Study-wide 139912 A=0.758262 G=0.241738
gnomAD - Genomes European Sub 75722 A=0.70492 G=0.29508
gnomAD - Genomes African Sub 41968 A=0.87402 G=0.12598
gnomAD - Genomes American Sub 13636 A=0.76423 G=0.23577
gnomAD - Genomes Ashkenazi Jewish Sub 3318 A=0.6414 G=0.3586
gnomAD - Genomes East Asian Sub 3118 A=0.6148 G=0.3852
gnomAD - Genomes Other Sub 2150 A=0.7279 G=0.2721
Allele Frequency Aggregator Total Global 28614 A=0.73359 G=0.26641
Allele Frequency Aggregator European Sub 21250 A=0.69506 G=0.30494
Allele Frequency Aggregator African Sub 5558 A=0.8820 G=0.1180
Allele Frequency Aggregator Other Sub 806 A=0.744 G=0.256
Allele Frequency Aggregator Latin American 2 Sub 610 A=0.766 G=0.234
Allele Frequency Aggregator Latin American 1 Sub 146 A=0.788 G=0.212
Allele Frequency Aggregator Asian Sub 146 A=0.596 G=0.404
Allele Frequency Aggregator South Asian Sub 98 A=0.51 G=0.49
14KJPN JAPANESE Study-wide 28242 A=0.74520 G=0.25480
8.3KJPN JAPANESE Study-wide 16756 A=0.74678 G=0.25322
1000Genomes_30x Global Study-wide 6404 A=0.7082 G=0.2918
1000Genomes_30x African Sub 1786 A=0.9272 G=0.0728
1000Genomes_30x Europe Sub 1266 A=0.6998 G=0.3002
1000Genomes_30x South Asian Sub 1202 A=0.4359 G=0.5641
1000Genomes_30x East Asian Sub 1170 A=0.6145 G=0.3855
1000Genomes_30x American Sub 980 A=0.765 G=0.235
1000Genomes Global Study-wide 5008 A=0.7021 G=0.2979
1000Genomes African Sub 1322 A=0.9236 G=0.0764
1000Genomes East Asian Sub 1008 A=0.6230 G=0.3770
1000Genomes Europe Sub 1006 A=0.7117 G=0.2883
1000Genomes South Asian Sub 978 A=0.433 G=0.567
1000Genomes American Sub 694 A=0.761 G=0.239
Genetic variation in the Estonian population Estonian Study-wide 4480 A=0.7603 G=0.2397
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 A=0.6751 G=0.3249
UK 10K study - Twins TWIN COHORT Study-wide 3708 A=0.6777 G=0.3223
KOREAN population from KRGDB KOREAN Study-wide 2874 A=0.6743 C=0.0000, G=0.3257
Korean Genome Project KOREAN Study-wide 1772 A=0.6795 G=0.3205
Northern Sweden ACPOP Study-wide 600 A=0.733 G=0.267
SGDP_PRJ Global Study-wide 284 A=0.310 G=0.690
Qatari Global Study-wide 216 A=0.602 G=0.398
A Vietnamese Genetic Variation Database Global Study-wide 212 A=0.528 G=0.472
The Danish reference pan genome Danish Study-wide 40 A=0.65 G=0.35
Siberian Global Study-wide 38 A=0.39 G=0.61
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 5 NC_000005.10:g.1295234A>C
GRCh38.p14 chr 5 NC_000005.10:g.1295234A>G
GRCh38.p14 chr 5 NC_000005.10:g.1295234A>T
GRCh37.p13 chr 5 NC_000005.9:g.1295349A>C
GRCh37.p13 chr 5 NC_000005.9:g.1295349A>G
GRCh37.p13 chr 5 NC_000005.9:g.1295349A>T
TERT RefSeqGene (LRG_343) NG_009265.1:g.4814T>G
TERT RefSeqGene (LRG_343) NG_009265.1:g.4814T>C
TERT RefSeqGene (LRG_343) NG_009265.1:g.4814T>A
LOC110806263 genomic region NG_055467.1:g.707A>C
LOC110806263 genomic region NG_055467.1:g.707A>G
LOC110806263 genomic region NG_055467.1:g.707A>T
Gene: TERT, telomerase reverse transcriptase (minus strand) : 2KB Upstream Variant
Molecule type Change Amino acid[Codon] SO Term
TERT transcript variant 2 NM_001193376.3:c. N/A Upstream Transcript Variant
TERT transcript variant 1 NM_198253.3:c. N/A Upstream Transcript Variant
TERT transcript variant 3 NR_149162.3:n. N/A Upstream Transcript Variant
TERT transcript variant 4 NR_149163.3:n. N/A Upstream Transcript Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: G (allele ID: 520856 )
ClinVar Accession Disease Names Clinical Significance
RCV000648941.7 Dyskeratosis congenita, autosomal dominant 2,Idiopathic Pulmonary Fibrosis Benign
RCV001653969.3 not provided Benign
RCV001816613.3 not specified Benign
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement A= C G T
GRCh38.p14 chr 5 NC_000005.10:g.1295234= NC_000005.10:g.1295234A>C NC_000005.10:g.1295234A>G NC_000005.10:g.1295234A>T
GRCh37.p13 chr 5 NC_000005.9:g.1295349= NC_000005.9:g.1295349A>C NC_000005.9:g.1295349A>G NC_000005.9:g.1295349A>T
TERT RefSeqGene (LRG_343) NG_009265.1:g.4814= NG_009265.1:g.4814T>G NG_009265.1:g.4814T>C NG_009265.1:g.4814T>A
LOC110806263 genomic region NG_055467.1:g.707= NG_055467.1:g.707A>C NG_055467.1:g.707A>G NG_055467.1:g.707A>T
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

62 SubSNP, 18 Frequency, 3 ClinVar submissions
No Submitter Submission ID Date (Build)
1 TSC-CSHL ss1343109 Oct 08, 2002 (108)
2 SC_JCM ss4040335 Sep 28, 2001 (100)
3 BCM_SSAHASNP ss10212500 Jul 11, 2003 (116)
4 ABI ss44657495 Mar 13, 2006 (126)
5 SNP500CANCER ss48297101 Mar 13, 2006 (126)
6 EGP_SNPS ss49784092 Mar 13, 2006 (126)
7 BGI ss105900037 Feb 06, 2009 (130)
8 COMPLETE_GENOMICS ss161945076 Jul 04, 2010 (132)
9 1000GENOMES ss232792232 Jul 14, 2010 (132)
10 BL ss253148873 May 09, 2011 (134)
11 SSMP ss651990300 Apr 25, 2013 (138)
12 EVA-GONL ss981163884 Aug 21, 2014 (142)
13 JMKIDD_LAB ss1072325238 Aug 21, 2014 (142)
14 1000GENOMES ss1313599942 Aug 21, 2014 (142)
15 EVA_GENOME_DK ss1580975924 Apr 01, 2015 (144)
16 EVA_DECODE ss1590679963 Apr 01, 2015 (144)
17 EVA_UK10K_ALSPAC ss1612108729 Apr 01, 2015 (144)
18 EVA_UK10K_TWINSUK ss1655102762 Apr 01, 2015 (144)
19 WEILL_CORNELL_DGM ss1924420004 Feb 12, 2016 (147)
20 JJLAB ss2022803427 Sep 14, 2016 (149)
21 USC_VALOUEV ss2150953407 Dec 20, 2016 (150)
22 HUMAN_LONGEVITY ss2270758478 Dec 20, 2016 (150)
23 SYSTEMSBIOZJU ss2625900226 Nov 08, 2017 (151)
24 GRF ss2706474619 Nov 08, 2017 (151)
25 ILLUMINA ss2711026300 Nov 08, 2017 (151)
26 GNOMAD ss2820319840 Nov 08, 2017 (151)
27 SWEGEN ss2996313964 Nov 08, 2017 (151)
28 BIOINF_KMB_FNS_UNIBA ss3025184464 Nov 08, 2017 (151)
29 CSHL ss3346200192 Nov 08, 2017 (151)
30 ILLUMINA ss3625864441 Oct 12, 2018 (152)
31 EGCUT_WGS ss3664202805 Jul 13, 2019 (153)
32 EVA_DECODE ss3713952222 Jul 13, 2019 (153)
33 ACPOP ss3732016622 Jul 13, 2019 (153)
34 EVA ss3762965747 Jul 13, 2019 (153)
35 PACBIO ss3784999180 Jul 13, 2019 (153)
36 PACBIO ss3790419594 Jul 13, 2019 (153)
37 PACBIO ss3795296072 Jul 13, 2019 (153)
38 KHV_HUMAN_GENOMES ss3806135124 Jul 13, 2019 (153)
39 EVA ss3829051954 Apr 26, 2020 (154)
40 SGDP_PRJ ss3861041557 Apr 26, 2020 (154)
41 KRGDB ss3907478606 Apr 26, 2020 (154)
42 KOGIC ss3955955314 Apr 26, 2020 (154)
43 TOPMED ss4647126194 Apr 26, 2021 (155)
44 TOMMO_GENOMICS ss5170044102 Apr 26, 2021 (155)
45 1000G_HIGH_COVERAGE ss5262607714 Oct 13, 2022 (156)
46 EVA ss5355157153 Oct 13, 2022 (156)
47 HUGCELL_USP ss5460980541 Oct 13, 2022 (156)
48 1000G_HIGH_COVERAGE ss5545525336 Oct 13, 2022 (156)
49 EVA ss5623931398 Oct 13, 2022 (156)
50 SANFORD_IMAGENETICS ss5624579660 Oct 13, 2022 (156)
51 SANFORD_IMAGENETICS ss5637025112 Oct 13, 2022 (156)
52 TOMMO_GENOMICS ss5705623860 Oct 13, 2022 (156)
53 EVA ss5800119948 Oct 13, 2022 (156)
54 YY_MCH ss5805951170 Oct 13, 2022 (156)
55 EVA ss5834408814 Oct 13, 2022 (156)
56 EVA ss5848038531 Oct 13, 2022 (156)
57 EVA ss5854645000 Oct 13, 2022 (156)
58 EVA ss5892681480 Oct 13, 2022 (156)
59 EVA ss5935747710 Oct 13, 2022 (156)
60 EVA ss5965432556 Oct 13, 2022 (156)
61 EVA ss5979728598 Oct 13, 2022 (156)
62 EVA ss5980274500 Oct 13, 2022 (156)
63 1000Genomes NC_000005.9 - 1295349 Oct 12, 2018 (152)
64 1000Genomes_30x NC_000005.10 - 1295234 Oct 13, 2022 (156)
65 The Avon Longitudinal Study of Parents and Children NC_000005.9 - 1295349 Oct 12, 2018 (152)
66 Genetic variation in the Estonian population NC_000005.9 - 1295349 Oct 12, 2018 (152)
67 The Danish reference pan genome NC_000005.9 - 1295349 Apr 26, 2020 (154)
68 gnomAD - Genomes NC_000005.10 - 1295234 Apr 26, 2021 (155)
69 KOREAN population from KRGDB NC_000005.9 - 1295349 Apr 26, 2020 (154)
70 Korean Genome Project NC_000005.10 - 1295234 Apr 26, 2020 (154)
71 Northern Sweden NC_000005.9 - 1295349 Jul 13, 2019 (153)
72 Qatari NC_000005.9 - 1295349 Apr 26, 2020 (154)
73 SGDP_PRJ NC_000005.9 - 1295349 Apr 26, 2020 (154)
74 Siberian NC_000005.9 - 1295349 Apr 26, 2020 (154)
75 8.3KJPN NC_000005.9 - 1295349 Apr 26, 2021 (155)
76 14KJPN NC_000005.10 - 1295234 Oct 13, 2022 (156)
77 TopMed NC_000005.10 - 1295234 Apr 26, 2021 (155)
78 UK 10K study - Twins NC_000005.9 - 1295349 Oct 12, 2018 (152)
79 A Vietnamese Genetic Variation Database NC_000005.9 - 1295349 Jul 13, 2019 (153)
80 ALFA NC_000005.10 - 1295234 Apr 26, 2021 (155)
81 ClinVar RCV000648941.7 Oct 13, 2022 (156)
82 ClinVar RCV001653969.3 Oct 13, 2022 (156)
83 ClinVar RCV001816613.3 Oct 13, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
14656000, ss3907478606 NC_000005.9:1295348:A:C NC_000005.10:1295233:A:C (self)
ss161945076, ss253148873, ss1590679963 NC_000005.8:1348348:A:G NC_000005.10:1295233:A:G (self)
25144237, 13984169, 9941053, 7140863, 14656000, 5301487, 6461934, 13058537, 3469761, 28013409, 13984169, 3100423, ss232792232, ss651990300, ss981163884, ss1072325238, ss1313599942, ss1580975924, ss1612108729, ss1655102762, ss1924420004, ss2022803427, ss2150953407, ss2625900226, ss2706474619, ss2711026300, ss2820319840, ss2996313964, ss3346200192, ss3625864441, ss3664202805, ss3732016622, ss3762965747, ss3784999180, ss3790419594, ss3795296072, ss3829051954, ss3861041557, ss3907478606, ss5170044102, ss5355157153, ss5623931398, ss5624579660, ss5637025112, ss5800119948, ss5834408814, ss5848038531, ss5935747710, ss5965432556, ss5979728598, ss5980274500 NC_000005.9:1295348:A:G NC_000005.10:1295233:A:G (self)
RCV000648941.7, RCV001653969.3, RCV001816613.3, 33051271, 177827874, 12333315, 39460964, 484503751, 5062387086, ss2270758478, ss3025184464, ss3713952222, ss3806135124, ss3955955314, ss4647126194, ss5262607714, ss5460980541, ss5545525336, ss5705623860, ss5805951170, ss5854645000, ss5892681480 NC_000005.10:1295233:A:G NC_000005.10:1295233:A:G (self)
ss1343109, ss4040335, ss44657495, ss48297101, ss49784092, ss105900037 NT_006576.16:1285348:A:G NC_000005.10:1295233:A:G (self)
ss10212500 NT_023089.13:1278086:A:G NC_000005.10:1295233:A:G (self)
ss5935747710 NC_000005.9:1295348:A:T NC_000005.10:1295233:A:T
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

73 citations for rs2853669
PMID Title Author Year Journal
19285750 Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Hosgood HD 3rd et al. 2009 Lung cancer (Amsterdam, Netherlands)
19380022 A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer. Varadi V et al. 2009 Cancer genetics and cytogenetics
20056641 Multiple genetic variants in telomere pathway genes and breast cancer risk. Shen J et al. 2010 Cancer epidemiology, biomarkers & prevention
21514219 Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Zhang B et al. 2011 The Lancet. Oncology
21949822 Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. Beesley J et al. 2011 PloS one
21994403 Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Liu Z et al. 2011 Cancer epidemiology, biomarkers & prevention
22134622 Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Zheng Y et al. 2012 Breast cancer research and treatment
22136229 Genetic variation in TERT and TERC and human leukocyte telomere length and longevity: a cross-sectional and longitudinal analysis. Soerensen M et al. 2012 Aging cell
23082138 Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease. Zhang W et al. 2012 PloS one
23535824 Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Kote-Jarai Z et al. 2013 Human molecular genetics
23908149 Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population. Zhong R et al. 2013 Molecular carcinogenesis
24101484 TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Rachakonda PS et al. 2013 Proceedings of the National Academy of Sciences of the United States of America
24171766 Common low-penetrance risk variants associated with breast cancer in Polish women. Ledwoń JK et al. 2013 BMC cancer
25140036 TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas. Simon M et al. 2015 Neuro-oncology
25296732 TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population. Shadrina AS et al. 2015 Tumour biology
25314060 TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. Labussière M et al. 2014 British journal of cancer
25331263 TERT promoter mutations in clear cell renal cell carcinoma. Hosen I et al. 2015 International journal of cancer
25448848 Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization. Muzza M et al. 2015 Molecular and cellular endocrinology
25487306 Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Carvajal-Carmona LG et al. 2015 Human genetics
25681309 Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis. Spiegl-Kreinecker S et al. 2015 Neuro-oncology
25809917 Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer. Hosen I et al. 2015 International journal of cancer
26143636 TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma. Mosrati MA et al. 2015 Oncotarget
26298771 Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis. Mosrati MA et al. 2015 Oncotarget
26354067 Replication of the results of genome-wide and candidate gene association studies on telomere length in a Korean population. Do SK et al. 2015 The Korean journal of internal medicine
26391479 TERT promoter mutations in soft tissue sarcomas. Campanella NC et al. 2016 The International journal of biological markers
26425038 TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population. Yoo SS et al. 2015 Journal of Korean medical science
26501986 Telomerase Reverse Transcriptase (TERT) Gene Variations and Susceptibility of Colorectal Cancer. Jannuzzi AT et al. 2015 Genetic testing and molecular biomarkers
26526580 Hotspot TERT promoter mutations are rare events in testicular germ cell tumors. Cárcano FM et al. 2016 Tumour biology
26575952 The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer. Ko E et al. 2016 Oncotarget
26608520 TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas. Nencha U et al. 2016 Journal of neuro-oncology
26621837 Common variations in TERT-CLPTM1L locus are reproducibly associated with the risk of nasopharyngeal carcinoma in Chinese populations. Zhang Y et al. 2016 Oncotarget
26875008 TERT promoter mutations in melanoma survival. Nagore E et al. 2016 International journal of cancer
26914704 The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism. Batista R et al. 2016 International journal of cancer
27016301 Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study. Bayram S et al. 2016 Gene
27336831 Association Between Human Telomerase Reverse Transcriptase Gene Variations and Risk of Developing Breast Cancer. Oztas E et al. 2016 Genetic testing and molecular biomarkers
27367732 Human Specific Regulation of the Telomerase Reverse Transcriptase Gene. Zhang F et al. 2016 Genes
27982019 The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer. Chen Z et al. 2017 Cancer gene therapy
27990595 Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients. Ofner R et al. 2017 Journal of cancer research and clinical oncology
28146043 Characterization of melanoma susceptibility genes in high-risk patients from Central Italy. Pellegrini C et al. 2017 Melanoma research
28371821 Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain. Gojo J et al. 2017 Neuro-oncology
28423629 Polymorphisms in human telomerase reverse transcriptase (hTERT) gene, gene- gene and gene-smoking interaction with susceptibility to gastric cancer in Chinese Han population. Zhang J et al. 2017 Oncotarget
28881610 Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: a systematic review and meta-analysis. Shen N et al. 2017 Oncotarget
28894890 New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma. Ersoy TF et al. 2017 Neuroradiology
28978027 Functional dissection of breast cancer risk-associated TERT promoter variants. Helbig S et al. 2017 Oncotarget
29506639 Genetic polymorphisms in human telomerase reverse transcriptase (hTERT) gene polymorphisms do not associated with breast cancer in patients in a turkish population: hospital-based case-control study. Aydin M et al. 2018 Cellular and molecular biology (Noisy-le-Grand, France)
29534075 Association between TERT rs2853669 polymorphism and cancer risk: A meta-analysis of 9,157 cases and 11,073 controls. Liu Z et al. 2018 PloS one
29938393 Possible association of the TERT promoter polymorphisms rs2735940, rs7712562 and rs2853669 with diabetes mellitus in obese elderly Polish population: results from the national PolSenior study. Gutmajster E et al. 2018 Journal of applied genetics
30535641 Correlation of human telomerase reverse transcriptase single nucleotide polymorphisms with in vitro fertilisation outcomes. Dai K et al. 2019 Journal of assisted reproduction and genetics
31270413
31425705 Classifying Melanoma by TERT Promoter Mutational Status. Shaughnessy M et al. 2020 The Journal of investigative dermatology
31446212 Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation. Yuan P et al. 2019 European journal of cancer (Oxford, England
31629678 Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry. Yang Y et al. 2019 EBioMedicine
31943527 Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma. Hirokawa T et al. 2020 Pathology international
31943533 Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development. Hirokawa T et al. 2020 Pathology international
32023888 TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients. Batista R et al. 2020 International journal of molecular sciences
32257207 Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women. Vinothkumar V et al. 2020 Molecular and clinical oncology
32257438 Association of TERT, OGG1, and CHRNA5 Polymorphisms and the Predisposition to Lung Cancer in Eastern Algeria. Mimouni A et al. 2020 Pulmonary medicine
32694935 Association between TERT gene polymorphisms and acute myeloid leukemia susceptibility in a Chinese population: a case-control study. Tong Y et al. 2020 Cancer cell international
33227798 Regulatory Single Nucleotide Polymorphism Increases TERT Promoter Activity in Thyroid Carcinoma Cells. Hirokawa T et al. 2020 Pathobiology
33389530 Association study of leukocyte telomere length and genetic polymorphism within hTERT promoter with type 2 diabetes in Bangladeshi population. Goswami A et al. 2021 Molecular biology reports
33547950 Human TERT promoter mutations as a prognostic biomarker in glioma. Powter B et al. 2021 Journal of cancer research and clinical oncology
33718071 Association of TERT gene polymorphisms with clinical benign prostatic hyperplasia in a Chinese Han population of the Northwest region. Fan G et al. 2021 Translational andrology and urology
33743166 Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis. Aziz MA et al. 2021 Human cell
33846459 Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus. Perez-Bercoff D et al. 2021 Scientific reports
34540891 Umbrella Review on Associations Between Single Nucleotide Polymorphisms and Lung Cancer Risk. Li X et al. 2021 Frontiers in molecular biosciences
34857839 TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia. Dratwa M et al. 2021 Scientific reports
34858826 Large Multicohort Study Reveals a Prostate Cancer Susceptibility Allele at 5p15 Regulating TERT via Androgen Signaling-Orchestrated Chromatin Binding of E2F1 and MYC. Dong X et al. 2021 Frontiers in oncology
34858860 TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma. Giunco S et al. 2021 Frontiers in oncology
35154531 TERT rs2853669 as a predictor for overall survival in patients with acute myeloid leukaemia. Tripon F et al. 2022 Archives of medical science
35159976 Assessment of Telomerase Reverse Transcriptase Single Nucleotide Polymorphism in Sleep Bruxism. Macek P et al. 2022 Journal of clinical medicine
35469904 Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort. Chang GA et al. 2022 The Journal of investigative dermatology
35704667 Evaluation of possible role of the hTERT gene rs2853669 polymorphism in the development of colorectal cancer as a genetic risk factor. Yalınbaş Kaya B et al. 2022 Nucleosides, nucleotides & nucleic acids
35962322 CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence. Ambrozkiewicz F et al. 2022 BMC cancer
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post761+d5e8e07